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Fatty acidsThe function of uncoupling protein 3 (UCP3) is still not established. Mitochondrial uncoupling, control of ROS
production, protectionagainst lipotoxicity andprotectionagainst oxidative stress are functions classicallydiscussed.
To establish a role forUCP3 in these functions,wehavehere usedUCP3 (−/−)mice, backcrossed for 10 generations
on a C57Bl/6 background. In isolated skeletal muscle mitochondria, we examined uncoupled respiration, both
unstimulated and in the presence of fatty acids. We did not observe any difference between mitochondria from
wildtype and UCP3 (−/−) mice. We measured H2O2 production rate and respiration rate under reactive oxygen
species-generating conditions (succinate without rotenone) but found no effect of UCP3.We tested twomodels of
acute lipotoxicity—fatty acid-induced oxidative inhibition and fatty acid-induced swelling—but did not observe any
protective effect of UCP3. We examined oxidative stress by quantifying 4-hydroxynonenal protein adducts and
protein carbonyls in the mitochondria—but did not observe any protective effect of UCP3.We conclude that under
the experimental conditions tested here, we ﬁnd no evidence for the function of UCP3 being basal or induced
uncoupling, regulation of ROS production, protection against acute lipotoxicity or protection against oxidative
damage.DNPH, dinitrophenylhydrazine;
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More than a decade after their identiﬁcation, the “novel” uncoupling
proteins—UCP2 and UCP3—remain without established functions. Al-
though a series of suggestions for function have been formulated over the
years, none have gained general acceptance. For most of this time, the
discussions (e.g. [1]) concerning UCP3 function have concentrated on the
following suggestions: that UCP3, similarly to UCP1, should be an
uncoupling protein [2]; that it is an uncoupling protein but only when
stimulated by certain activators [3]; that it controls ROS production [4];
that it is a fatty acid anion exporter [5]; that it could protect against
lipotoxicity [6,7]; and that it could protect against oxidative damage(induced by ROS production). Particularly this latter suggestion is
discussed and promoted in a large number of reviews (e.g. [6,8–11]).
The physiological function of a protein can be studied in several
ways. Particularly the outcomes of gene ablation experiments are
accepted as indications for the functional role of a given protein in a
given process. Concerning UCP3, several studies examining the above
statements in UCP3(−/−) mice have been published but there is
variation in the results. Inspection of the literature indicates that few
of the investigations of UCP3(−/−) mice have been performed with
backcrossed mice, and effects observed may therefore be related to
strain differences and not due to functions of UCP3 as such.
In the present investigation, we have therefore (re-)examined
experimental models for these suggested functions in skeletal muscle
mitochondria isolated from wildtype mice and from UCP3(−/−)
mice, backcrossed for 10 generations to the C57Bl/6 (wildtype) strain.
It is the outcome of the investigation that none of the proposed
functions, at least as examined under the conditions used here,
withstood this experimental testing.
2. Material and methods
2.1. Animals
Male C57Bl/6 mice lacking UCP3 (UCP3(−/−)) and their wildtype
controls, about 20 weeks of age, were derived from those generated
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backcrossed for 10 generations onto a C57Bl/6 background. Animals
were maintained on a 12:12 h light–dark cycle (light from 07.00 to
19.00 hours), at 21–22 °C and were allowed unlimited access to
standard laboratory chow and tap water. All experiments were
approved by the Animal Ethics Committee of the North Stockholm
region and of the Maastricht University and complied with the
principles of laboratory animal care.
2.2. Tissue collection and mitochondrial isolation
Mice were anesthetized by a mixture of 79% CO2 and 21% O2 and
killed by decapitation. Isolation of skeletal muscle mitochondria, 2 mice
per isolation, and determination of protein concentration were
performed as previously described [13]. Brieﬂy, hind limb skeletal
muscle (~2.0 g) was dissected and immediately placed into ice-cold
isolation buffer (100 mM sucrose, 50 mM KCl, 20 mM K+-TES, 1 mM
EDTA, and 0.2% (w/v) fatty acid-free bovine serum albumin). Tibialis
anterior muscle was held separate for western blot analysis and the
remaining tissue was ﬁnely minced with scissors, followed by
mechanical Potter homogenization in the presence of nagarse (Fluka
Chemie, GmbH, Germany; 1 mg/g tissue). Homogenates were centri-
fuged (8500g for 10 min at 4 °C) and the resulting pellets were
resuspended in isolation buffer. After hand-homogenization in a Potter
homogenizer, the suspensions were centrifuged (800g for 10 min at
4 °C). The pellet was discarded and the supernatant was again
centrifuged (8500g for 10 min at 4 °C). Theﬁnal resultingmitochondrial
pellets were gently resuspended by hand-homogenization in a small
glass homogenizer with a Teﬂon pestle.
Mitochondrial protein concentration was determined using ﬂuor-
escamine (Fluram®, Fluka Chemie, Gmbh, Germany) with albumin as
a standard.
2.3. Levels of mitochondrial proteins
Western blotting was performed in isolated skeletal muscle
mitochondria and in tissue homogenates. Coomassie Brilliant Blue
staining was used to determine the total protein content of every
sample. Subsequently, western blotting was performed using 10%
polyacrylamide SDS-gels as described before [14,15]. Gels were
loaded with 30 μg of protein per sample and equal protein loading
was conﬁrmed by western blotting of actin (for tissue homogenates)
and porin (for mitochondria). Rabbit polyclonal antibody against
UCP3 (code 1338, kindly provided by LJ Slieker, Eli Lilly, dilution
1:10000), as well as monoclonal antibodies against actin (A2172;
Sigma-Aldrich, St. Louis, MO, USA, dilution 1:250000), adenine
nucleotide translocase (ANT) (MSA02;Mitosciences, OR, USA, dilution
1:2000), porin (sc-58649; Santa Cruz, CA, USA, dilution 1:10000), and
a mixture of monoclonal antibodies against some of the structural
components of oxidative phosphorylation (Oxphos) complexes I, II, III
and V (MS601; Mitosciences, OR, USA, dilution 1:10000) were used.
The UCP3 protein band was visualized by chemiluminescence and
analyzed by densitometry using Image Master (Pharmacia Biotech,
Roosendaal, The Netherlands), whereas bands of other proteins were
detected and quantiﬁed with Odyssey Infrared Imager (LI-COR;
Wesburg, Leusden, The Netherlands).
2.4. Mitochondrial respiration studies
Skeletal muscle mitochondria (0.25 mg/ml) were incubated in a
medium consisting of 100 mM sucrose, 20 mM K+-Tes (pH 7.2),
50 mM KCl, 2 mM MgCl2, 1 mM EDTA, 4 mM KH2PO4, and 0.1% (w/v)
fatty acid-free bovine serum albumin. Oxygen consumption rates
were monitored with a Clark-type oxygen electrode (Yellow Springs
Instrument Co., USA) in a sealed chamber at 37 °C as described [13].
The substrates used were either 3 mMmalate plus 5 mM pyruvate, or5 mM succinate (here used in the absence of rotenone (if not
otherwise stated)); oligomycin (1 μg/ml) was added to block ATP
synthesis (“state-4 respiration”). For measurements of fatty acid-
stimulated respiration, the mitochondria were titrated with increas-
ing levels of palmitate (dissolved in 50% ethanol). The free
concentrations of palmitate were calculated using the equation
described in Ref. [16] for the binding of palmitate to albumin at
37 °C. Data for fatty acid concentration–response curves were
analyzed with the four parameter logistic curve ﬁt option of the
Sigmaplot 8.0 application for adherence to simple Michaelis–Menten
kinetics.
To assess the effect of fatty acids on maximal oxidative capacity, a
submaximal concentration of palmitate (100 μM, based upon the
palmitate-induced respiratory measurements) was added to the mito-
chondria in state-4 (pyruvate+malate present), while respiration was
monitored. Subsequently, the maximal capacity of the electron transport
chain was determined by addition of an amount (indicated) of the
chemical uncoupler carbonyl cyanide p-triﬂuoromethoxyphenylhydra-
zone (FCCP) that in additional experiments had been established to be
optimal (i.e. not inhibitory). In the control condition, palmitate was
replaced by its solvent (50% ethanol).
2.5. ROS production and effects
Mitochondrial H2O2 net production was determined ﬂuorometri-
cally by the use of the Amplex Red reagent (Invitrogen). Oxidation of
Amplex Red coupled by horseradish peroxidase to reduction of H2O2
produces the red ﬂuorescent oxidation product resoruﬁn [17].
Mitochondria (0.1 mg ofmitochondrial proteinml−1) were incubated
at 37 °C under magnetic stirring in the same buffer as that used for
respiration studies. All incubations also contained 5 μM Amplex Red,
12 units ml−1 horseradish peroxidase and 45 units ml−1 superoxide
dismutase. The reaction was initiated by addition of substrate (5 mM
succinate, or 5 mM pyruvate plus 3 mM malate); this was followed
after 3–4 min by addition of rotenone (2 μM). The increase in
ﬂuorescence at an excitation wavelength of 545 nm and emission
via Band Pass Filter 600±20 nm was followed in a 3 ml cuvette for
8–10 min with a Sigma spectroﬂuorometer. The rate of H2O2
production was calculated as the change in ﬂuorescence intensity
during the linear increase (as described before [18]). Calibration
curves were obtained by adding known amounts of freshly diluted
H2O2 (concentration of stock solution was checked at 240 nm using a
molar extinction coefﬁcient of 43.6) to the assay medium. The
standard curve was linear in a range up till 900 nM H2O2.
2.6. Fatty acid-induced mitochondrial swelling
Fatty acid-induced swelling of freshly isolated mitochondria
(0.25 mg) was monitored as change in absorbance at 540 nm using
an Aminco DW-2 UV-VIS spectrophotometer as described before [19].
The incubation medium and experimental conditions were the same
as described for oxygen consumption experiments with pyruvate
(5 mM) and malate (3 mM) as substrates. An initial addition of oleate
(200 μM) was followed by 20 μM titrations. Titrations with solvent
(50% ethanol) were performed as control to check for spontaneous
swelling.
2.7. Lipid peroxidation and oxidative modiﬁcation of mitochondrial proteins
The level of 4-HNE-adducts was determined by Western blot
(principally as described before [20,21] using rabbit polyclonal
antibodies detecting mouse 4-HNE-Michael adducts (Calbiochem,
San Diego, CA, USA, dilution 1:1000). 4-HNE adduct bands between 30
and 100 kDa were detected and quantiﬁed as total absorbance with
Odyssey Infrared Imager (LI-COR;Wesburg, Leusden, The Netherlands).
To show in-vitro 4-HNE adduct formation, wildtype skeletal
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for 20 min at 37 °C in the medium used for the oxygen consump-
tion measurements.
The amount of protein carbonyls was determined using Oxyblot
protein oxidation detection kit (Millipore, Billerica, MA, USA). Mitochon-
driawere 10 times diluted in a buffer containingHEPES (50 mM, pH7.4),
triton-X-100, EGTA (3.6 mM, pH 7.5), EDTA (9 mM, pH 7.5), DTT
(50 mM), PMSF (1 mM) and complete protease inhibitor cocktail
(EDTA free, Roche Diagnostics, Mannheim, Germany). After 2 h
incubation at 4 °C, the samples were centrifuged for 15 min at 17,500g
at 4 °C. Subsequently, the supernatant was removed and used for
Bradford protein determination (Bio-Rad laboratories, Veenendaal, The
Netherlands). Fivemicroliters diluted sample (3 μg sample/μl buffer)was
added to 5 μl SDS (12%) for denaturation and vortexed. Samples were
derivatized by a 10 μl addition of 1 × DNPH, mixed and incubated for
15 min at room temperature where after 7.5 μl of neutralization solution
was added. Samples (3 μg protein) were loaded onto a 12% polyacryl-
amide gel and blotted for 60 min at 100 V. Membranes were blocked in
PBS:LI-COR buffer (LI-COR, Wesburg, Leusden, The Netherlands, dilution
1:1) for 1 h and then incubated with primary rabbit antibody against
DNPH moieties (Millipore, dilution 1:150) for 1 h. Donkey anti rabbit
antibody conjugated with Alexa 488 (LI-COR, dilution 1:10.000) was
usedas secondary antibodyand incubated for 1 h. Protein carbonyl bands
between 30 and 100 kDawere detected and quantiﬁedwith theOdyssey
Infrared Imager. Negative control reactions were performed with
derivatization control solution, as opposed to the reaction with 2,4-
dinitrophenylhydrazine (DNPH). To show in-vitro protein carbonylation,
wildtype skeletal musclemitochondriawere incubated in the absence or
presence of 25 mM ascorbate and 400 μM Fe2+ for 1 h at 37 °C in the
same medium as that used for the oxygen consumption measurements.
2.8. Investigating in-vitro endogenous 4-HNE adduct formation
Freshly isolatedmitochondria (0.5 mg), wildtype and UCP3(−/−),
were incubated for 1 h at 37 °C in mitochondrial respiration buffer
supplemented with oligomycin (1 μg/ml) under 4 conditions:
1) succinate (5 mM) in the absence of rotenone. 2) succinate plus
linolenic acid (100 μM). 3) and 4) as in 1) and 2) but in the presence of
rotenone (2 μg/ml). After 1 h, the solution was centrifuged for 5 min
at 15,000g. The mitochondrial pellet was washed once with
phosphate buffered saline (PBS) and centrifuged again. The ﬁnal
mitochondrial pellet was diluted in PBS and Laemmli sample buffer
(Bio-Rad Laboratories) in a 2:1 ratio, obtaining solutions of about
7 μg/μl of protein. Subsequently samples were heated at 100 °C for
4 min, centrifuged at 15,000g for 5 min and frozen at −20 °C for
subsequent analysis of 4-HNE protein adducts as above. Five
independent experimental series were executed.
2.9. Statistics
Statistical analyses were performed using SPSS for Windows 11.0
software (SPSS Inc., Chicago, IL, USA) by unpaired t-test with
statistical signiﬁcance threshold set at P=0.05. Results are presented
as means±SEM.
3. Results
3.1. UCP3, adenine nucleotide transporter, and Oxphos protein expression
We ﬁrst validated the phenotype of the mice. As seen in Fig. 1A,
UCP3 was only detected in the skeletal muscle preparations from
wildtypemice. To examine if the lack of UCP3was compensated for by
an increase in adenine nucleotide transporter (ANT) (as has been
discussed [22]), we examined the ANT level by immunoblotting, as
exempliﬁed in Fig. 1B (upper panel). As seen from the compilation
from ﬁve preparations from each genotype (lower panel), there wasno increase in ANT amount in the UCP3(−/−) mice. Protein levels of
the oxidative phosphorylation complexes (Oxphos), a marker for
mitochondrial content, were similar in skeletal muscle homogenates
of both genotypes (Fig. 1C and Table 1).
3.2. Mitochondrial respiration in the absence or presence of fatty acids
Functionally, we ﬁrst examined the effect of UCP3 ablation on
uncoupled respiration under different conditions. The basal rate of
mitochondrial respiration, i.e. the rate that is not coupled to ATP
synthesis (i.e. state-4 respiration), was examined in mitochondria
incubated with pyruvate plus malate as substrate, in the presence of
oligomycin, as exempliﬁed in the ﬁrst part of the oxygen electrode
trace in Fig. 2A. The presence (versus the absence) of UCP1 in (brown-
fat) mitochondria leads to a high rate of uncoupled respiration
[23–25]. If UCP3 had a similar direct uncoupling effect, a higher
respiration rate would have been anticipated in the mitochondria
from the wildtype mice than in those from UCP3(−/−) mice.
However, we found state-4 respiration rate to be similar in skeletal
muscle mitochondria from UCP3(−/−) and wildtype mice (Fig. 2B).
Thus, in contrast to UCP1, UCP3 does not seem to possess an innate
uncoupling effect—or the capacity is so small that it is not discernable.
All mitochondria respond to fatty acids with increased basal
respiration (uncoupling), likely due to fatty acid interaction with the
isoform 2 of the ANT [25]. The presence of UCP1 endows mitochondria
with amuch enhanced response to fatty acids, evenwhen UCP1 is GDP-
inhibited [24]. In extension of this, fatty acids have been suggested to be
activators of UCP3 [26,27].We therefore testedwhether the presence of
UCP3 endowed the skeletal muscle mitochondria with enhanced fatty
acid sensitivity with respect to uncoupling.
As expected, palmitate stimulated uncoupled respiration in
skeletal muscle mitochondria in a dose-dependent manner (Fig. 2A
and C). Calculated EC50 values (140±16 vs 147±21 nmol free
palmitate, in UCP3(−/−) and wildtype, respectively) and Vmax values
(281±20 vs 284±16 nmol O2/min/mg, in UCP3(−/−) and wildtype,
respectively) were similar in UCP3(−/−) and wildtype mice. Thus,
fatty-acid-induced uncoupling was similar in UCP3(−/−) and wild-
type mice, excluding a role for fatty acids in inducing an uncoupling
activity of UCP3.
3.3. Rate of ROS production
It has been suggested that a function of UCP3 is to diminish the rate
of ROS production [4,28]. We therefore measured ROS (in the form of
H2O2) production rate in wildtype and UCP3(−/−) mice, as
exempliﬁed in Fig. 3A.
We ﬁrst examined ROS production with pyruvate plus malate as
mitochondrial substrate. As seen in the compilation in Fig. 3B, we
were unable to observe any difference in ROS production rate
between mitochondria from wildtype and UCP3(−/−) mice.
We then examined ROS production under conditions of reverse
electron ﬂow, i.e. in the presence of succinate without rotenone, is a
condition known to lead to a high net superoxide release [19,29]. We
both measured H2O2 production from Complex I (i.e. succinate in the
absence of rotenone) and from Complex III (after rotenone). As seen
both in the trace in Fig. 3A and in the compilation in Fig. 3B, we
induced a high rate of H2O2 production with succinate minus
rotenone—but we obtained exactly the same H2O2 production rate
inmuscle mitochondria fromwildtype and UCP3(−/−) mice.We ﬁnd
therefore no evidence for a protective role of UCP3 against ROS
production.
Formally, this result is in contrast to that of Toime and Brand [28]
who reported that they could detect an≈12% higher rate of H2O2
production in muscle mitochondria from backcrossed UCP3(−/−)
mice than that from wildtype mice. The experiments of Toime and
Brand were conducted under experimental conditions very similar to
Fig. 1. UCP3 and adenine nucleotide transporter (ANT) protein levels and levels of structural components of the oxidative phosphorylation in skeletal muscle of wildtype (WT) and
UCP3(−/−) mice. A) Representative western blot of UCP3 protein levels in skeletal muscle homogenates ofWT and UCP3(−/−) mice. As expected, UCP3 was only present in theWT
mice and could not be detected in UCP3(−/−) mice. B) Representative western blot (upper panel) and quantiﬁcation (lower panel) of ANT protein levels in skeletal muscle
mitochondria from WT and UCP3(−/−) mice (n=5). Black bar represents WT mice and grey bar UCP3(−/−) mice. C) Representative western blot of structural components of
oxidative phosphorylation in skeletal muscle homogenates from WT and UCP3(−/−) mice. (Quantiﬁcation of this western blot is shown in Table 1).
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here) or a small effect (as reported by Toime and Brand) that is a
statistical coincidence is not possible to establish.
3.4. Effect of ROS on UCP3 activity
As mentioned above, it has been suggested that UCP3 may only
function as a proton channel when it is activated [3]. In addition to
fatty acids tested above as activators (Section 3.2), another suggested
activator is superoxide [29,30]. To examine whether the endogenous-
ly released superoxide was able to activate UCP3, we incubated the
mitochondria under the conditions above, i.e. in the presence of
succinate without rotenone, creating a high net superoxide release (as
veriﬁed in Fig. 3). However, we did not under these conditions detect
a difference in mitochondrial respiration rate between UCP3(−/−)Table 1
Muscle content of structural components of oxidative phosphorylation.
Wildtype UCP3(−/−)
Complex I 0.24±0.03 0.31±0.03
Complex II 0.53±0.08 0.67±0.09
Complex III 1.27±0.20 1.41±0.15
Complex V 0.16±0.02 0.19±0.03
Total complexes 2.20±0.31 2.55±0.21
Quantiﬁcation of western blot signal intensity of structural components of the oxidative
phosphorylation from skeletal muscle homogenates of wildtype and UCP3(−/−) mice.
Values are arbitrary units. Although all complexes showed a tendency to a 10–20%
higher content in the preparation from UCP3(−/−), this difference was not signiﬁcant
(n=5).and wildtype mice (Fig. 4A and B). Thus, despite equal and high rates
of H2O2 production, there was no indication that an uncoupling
activity of UCP3 was induced.
It has been stated that whereas the suggested activating role of
ROS on UCP3 demands the presence of fatty acids if the ROS is
exogenously produced [30], this is not the case when superoxide is
endogenously produced [29]. According to this, fatty acids would not
be needed in the experiments described above (Fig. 4). To examine
the possibility that the reason that we could not observe an enhancing
effect of the presence of UCP3 in Fig. 3 anyhow was the absence of
dual stimulation by fatty acids and ROS, we tested the effect of further
respiratory stimulation with addition of fatty acids, principally as in
Fig. 2A, but with succinate (without rotenone) as substrate (Fig. 4A).
With palmitate additions corresponding to free palmitate concentra-
tions of 10 and 30 nM, we were again able to stimulate respiration (as
in Fig. 2A and C), but the effect of the palmitate additions was (if
anything) lower than under the previous conditions (Fig. 2C) where
ROS was not present (thus there was no “dual stimulation effect”),
and there was no difference between the response in wildtype and
UCP3(−/−) mitochondria (Fig. 4C). With higher palmitate concen-
trations we started to observe confounding inhibitory effects of fatty
acids on succinate oxidation, as expected.3.5. Acute lipotoxicity
It has been suggested that UCP3 may protect against lipotoxicity
[31]. We have here examined two conditions which may be said to
exemplify acute lipotoxicity.
Fig. 2. Mitochondrial respiration in skeletal muscle mitochondria isolated from
wildtype and UCP3(−/−). A) Representative recording of basal respiration in wildtype
skeletal muscle mitochondria using pyruvate (5 mM) and malate (3 mM) as substrates
in the presence of oligomycin (1 μg/ml) and fatty acids. B) The state-4 rate (n=5).
C) Palmitate concentration-oxygen consumption response curves of wildtype and UCP3
(−/−) mice (n=5).
Fig. 3. The rate of ROS production in mitochondria from wildtype and UCP3(−/−) mice.
A) Traces (from wildtype mitochondria) of H2O2 production after addition of different
substrates (5 mM pyruvate plus 3 mM malate, or 5 mM succinate) and 2 μM rotenone.
B) Compilation of data obtained from 4 preparations of wildtype and UCP3(−/−)
mitochondria, examined as in A). Whereas a tendency to a somewhat longer lagtime after
succinate addition could bediscerned inUCP3(−/−)mitochondria (not shown), the stable
rates of H2O2 production were not different between the two types of mitochondria.
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First we tested the effect of direct addition of fatty acids on
maximal mitochondrial oxidative capacity. We examined muscle
mitochondria respiring on pyruvate. In the control condition we
added the fatty acid solvent ethanol to the mitochondria and then
measured the maximal respiratory capacity as observed after addition
of the chemical uncoupler FCCP (Fig. 5A). We then repeated the
experiment when FCCP was added after addition of a fairly high dose
of fatty acid (Fig. 5B). The addition of this dose of fatty acid led to
diminished maximal oxidative capacity (Fig. 5C). However, the
absence of UCP3 did not aggravate the inhibitory effect of fatty acids
on maximal oxidative capacity (Fig. 5C).
3.5.2. Mitochondrial swelling
The second condition for testing the ability of UCP3 to protect
against acute lipotoxicity was fatty acid-induced mitochondrial
swelling. We performed experiments as illustrated in Fig. 6A and B.
As seen, successive additions of oleate led successively to highamplitude swelling; no spontaneous swelling was seen when
mitochondria were incubated for 30 min at 37 °C with solvent (50%
ethanol) only (Fig. 6A and B). As compiled in Fig. 6C, themitochondria
from wildtype and UCP3(−/−) mice were equally sensitive to oleate.
Maximal swelling as induced by alamethicin was also similar in both
groups (not shown). Thus, also in this test, the absence of UCP3 failed
to aggravate the lipotoxicity.
3.6. Oxidative stress
To examine whether UCP3 protects against oxidative stress, we
examined two measures of oxidative damage.
3.6.1. Lipid peroxidation products
Oxidative stress (ROS production) often leads to lipid peroxidation
with 4-hydroxynonenal (4-HNE) being one of the major, highly
reactive products [32]. 4-HNE would react irreversibly with certain
amino acids on themitochondrial proteins, leading to accumulation of
4-HNE protein adducts, which can thus be seen as a measure of
oxidative damage. We initially demonstrated that oxidative damage
can be observed in this way in the system here investigated. For this,
we made in-vitro additions of 4-HNE to muscle mitochondria. As seen
in Fig 7A, these additions lead to increased levels of adducts in the
muscle mitochondria (just as it did in brown-fat mitochondria [20]),
verifying that the adducts would be detectable. We have also earlier
demonstrated in-vivo that in mice with enhanced levels of the
mitochondrial superoxide dismutase, the 4-HNE levels weremarkedly
lowered, demonstrating that levels of adducts in isolated mitochon-
dria reﬂect in-vivo modiﬁcations [13]. That different physiological
conditions can lead to altered levels of 4-HNE adducts has been shown
both in experimental animals [33,34] and in humans [18].
Fig. 4. Effect of ROS production on respiratory rates in mitochondria from wildtype and
UCP3(−/−) mice. A) Respiratory traces under conditions of high endogenous ROS
production. B) The rate of state-4 measured under reversed electron ﬂow (high
endogenous superoxide production) (n=4). C) The increase in oxygen consumption
caused by added palmitate (n=4). The stippled curves indicated by “pyr” (pyruvate)
are from Fig. 2C and thus show the uncoupling effect of palmitate in the absence of
endogenously produced ROS.
Fig. 5. The effect of palmitate on the maximal oxidative capacity of isolated skeletal
muscle mitochondria from wildtype (WT) and UCP3(−/−) mice. FCCP was used to
chemically induce uncoupling and to stimulate mitochondria to maximal respiration, at
a concentration of 1 μM or 1.5 μM dependent on the amount necessary to induce
maximal mitochondrial respiration. A) Representative recordings of maximal mito-
chondrial oxygen consumption, monitored in presence of pyruvate (5 mM) and malate
(3 mM) as substrates. Ethanol (the palmitate vehicle) was used as a control.
B) Representative recordings of the effect of palmitate on the maximal oxidative
capacity of isolated mitochondria of UCP3(−/−) and wildtype mice. Maximal
mitochondrial oxygen consumption was monitored upon addition of 100 μM palmitate
in presence of pyruvate and malate as substrate. C) The percentage decrease upon
palmitate addition as compared to ethanol was calculated per mitochondrial isolation
and averaged per genotype. Black bars represent the percentage decrease for wildtype
and gray bars that for UCP3(−/−) mice (n=5).
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in skeletal muscle mitochondria from wildtype mice (Fig. 7B).
However, the level of these adducts was not increased in the
mitochondria from the UCP3(−/−) mice (Fig. 7C).
3.6.2. Protein carbonyl groups
Also formation of protein carbonyls is generally used as amarker of
oxidative stress [35]. To verify that oxidative conditions can increaseprotein carbonylation in these mitochondria, we incubated mito-
chondria under such conditions (i.e. with Fe2+ and ascorbate). As
seen in Fig. 7D, this increased the level of carbonylation. Also this
marker of oxidative damage was clearly seen in mitochondria from
wildtype mice (Fig. 7E), but again no signiﬁcant increase was seen in
mitochondria from UCP3(−/−) mice (Fig. 7F).
3.6.3. Effects of prolonged in-vitro endogenous oxidative stress
To examine whether a protective effect of UCP3 could be manifest
under conditions where endogenous formation of 4-HNE adducts was
enhanced, we incubated wildtype and UCP3(−/−) mitochondria for
1 h at 37 °C under the combined conditions of high endogenous
superoxide production (succinate without rotenone) and added
Fig. 6. Mitochondrial membrane swelling upon fatty acid addition. Oleate-induced
swelling of skeletal muscle mitochondria from wildtype (WT) (A) and UCP3(−/−) (B)
mice. Pyruvate (5 mM) and malate (3 mM) were used as substrates. Ethanol (EtOH,
50%) (solvent) was used as a control to check for spontaneous swelling. C) Cumulative
oleate–response curves for wildtype (WT) and UCP3(−/−) mice. Oleate induced
mitochondrial swelling, visible as a decrease in absorbance, in concentrations N200 μM.
The cumulative decrease in absorbance upon oleate titration (20 μM additions) was
calculated and depicted as a function of oleate concentration (n=5).
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see any effect of the presence or absence of UCP3 on the formation of
4-HNE adducts under these conditions (not shown).
4. Discussion
In the present investigation, we have demonstrated that the
presence of UCP3 in muscle mitochondria does not in itself increase
the basal respiration of the mitochondria, nor the respiration seenafter addition of fatty acids. We found that UCP3 did not alter the rate
of endogenously produced superoxide and that even in the presence
of such superoxide, no effect of the presence of UCP3 on respiratory
rate was seen. We found no indication that UCP3 protected the
mitochondria against acute lipotoxicity or against oxidative stress
under our experimental conditions. Thus, the present experiments do
not support a role for UCP3 either as an uncoupling protein, or as a
protector against lipotoxicity or oxidative stress.
4.1. UCP3 and uncoupled respiration
We deﬁne here the basal respiration as state-4 respiration, i.e.
respiration under conditions where ATP synthesis is not taking place.
We did not ﬁnd evidence that UCP3 in itself increased this basal
respiration of isolated mitochondria (Fig. 2A and B). This is in contrast
to what was observed in one of the original papers on the UCP3(−/−)
mouse [36] but is in agreement with the other [12]. However, in these
ﬁrst reports, the UCP3(−/−) mice were not backcrossed. In later
studies (where it is not clearly indicated whether the mice were
backcrossed or not), an increased basal respiration has also not been
observed [30,37–39]. Respiratory studies have also been performed
where it has been stated that the muscle mitochondria were from
backcrossed UCP3(−/−) mice but the data have not been analyzed
for basal respiration [22]. We used a complex I-linked substrate
(pyruvate) for this study, in contrast to the studies quoted above that
all used succinate (thus, our reported mitochondrial respiratory rates
are much lower than those reported elsewhere), but, taken together,
it is clear that the absence of effect of UCP3 observed by us is not
secondary to the substrate used (i.e. it is not an issue whether suc-
cinate could possibly induce a somewhat higher membrane potential
than pyruvate).
We have not measured membrane potential here and we can
therefore formally not state that UCP3 is not associated with a proton
leak. However, in accepted Mitchellian bioenergetics, an increased
respiration rate must necessarily be associated with an increased
proton leak, everything else being equal. Thus, all these data indicate
that UCP3 is not associated with an innate proton leak.
In agreement with the observations here of an absence of effect of
ablating UCP3, there is a series of studies that demonstrate that
physiologically induced increased levels of UCP3 are not associated
with higher rates of basal uncoupled respiration [13,40–45]. Effects of
increased UCP3 levels induced by transfection are difﬁcult to evaluate
[46] and will not be discussed here.
Earlier tenets that UCP3 (uncoupling) activities could be estimated
indirectly as being equal to the inhibitory effect of addition of GDP
cannot be discussed presently, as it is now clear that GDP interacts
with ANT [39,47,48] (whereas an interaction with UCP3 actually
presently is less clear, at least as judged from state-4 respiratory data
[13,39,49]). (When calculated as proton leak at a ﬁxed voltage, GDP
has been reported to have a UCP3-related inhibitory effect [39]—but,
bioenergetically confounding, the decreased proton leak estimated in
this way was not associated with a decreased state-4 respiration, and
it is therefore difﬁcult to comprehend what such a proton leak mea-
surement represents).
Thus, the conclusion from all the above studies must be that in
contrast towhatwas originally assumed, and in contrast towhat is the
case for UCP1 [50] (or for ANT isoform 1 [25,51]), UCP3 is not an
uncoupling protein, i.e. UCP3 in itself does not innately increase
mitochondrial proton leak.
4.2. UCP3 and ROS production
One suggested function of UCP3 is protection against formation of
reactive oxygen species (ROS) [28,52]. We have here measured ROS
production in the form of H2O2 formation under different conditions:
forward and reverse electron ﬂow, Complex I- and Complex II-linked
Fig. 7. Oxidative damage measured by Western blotting of skeletal muscle mitochondria from UCP3(−/−) and wildtype (WT) mice. A) Demonstration of in-vitro 4-HNE adduct
formation. B) Representative 4-HNE Western blot. C) Quantiﬁcation of Western blots (n=4) of the 4-HNE protein adducts. D) Demonstration of in-vitro protein carbonylation.
E) Representative Western blot. F) Quantiﬁcation of Western blots (n=5) of protein carbonyl products. Black bars represent wildtype mice and grey bars UCP3(−/−) mice.
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not observed any difference on ROS production between UCP3-
containing or UCP3-lacking mitochondria. Seifert et al. [53] also
observed identical levels of H2O2 production in muscle mitochondria
from wildtype and UCP3(−/−) mice. Thus, these results do not
support the tenet that UCP3 protects against ROS formation.
Themechanism underlying the suggested protective effect of UCP3
against ROS production has been formulated to be a “mild uncou-
pling", meaning a small decrease in membrane potential. There is
good evidence that a minor decrease in membrane potential leads to
reduction in succinate-supported ROS production [54]; such a
decrease in membrane potential is necessarily, according to Mitch-
ellian bioenergetics, also leading to increase in respiration (a 90%
decrease in ROS production concomitant with a 300% increase in
respiration was originally observed [54]). As our condition leading to
high ROS production (Fig. 3) did not lead to activation of uncoupling
(i.e. increased respiration) (Fig. 4), it cannot have led to decreased
membrane potential and thus cannot have counteracted an (further)
increase in ROS production. In general, as it does not seem that UCP3
has any uncoupling (membrane potential decreasing) effect, it is
difﬁcult to understand how it could reduce ROS production: a novel,
not membrane-potential-linked mechanism would need to be
formulated (as pointed out earlier [55]).
4.3. UCP3 and induced uncoupled respiration
Although initial views on UCP3 function implied a direct
uncoupling effect of the protein, later suggestions have been that it
only functions as a proton leak if induced by certain activators. We
have here tested fatty acids and reactive oxygen species as activators
but we were unable to identify a UCP3-mediated effect of these
agents.4.3.1. Fatty acids as potential UCP3 activity inducers
Particularly based on experiments in reconstituted systems
(liposomes and black lipid membranes), it has been suggested that
fatty acids could be activators of UCP3 [27]. We examined this
possibility here by titrating fatty acids (palmitate) in muscle
mitochondria fromwildtype and UCP3(−/−) mice.We used pyruvate
as substrate for respiration; under the conditions used here the
palmitate cannot be a substrate as it cannot be oxidized in the
mitochondria in the absence of CoA, ATP and carnitine (and after
treatment of the mitochondria with nagarse). We found no differ-
ences between the uncoupling activity of fatty acids in wildtype and
UCP3(−/−) mitochondria (Fig. 2A and C). These results are
principally in agreement with those of Cadenas et al. [37] and those
of Lombardi et al. [38]. As Lombardi et al. used the polyunsaturated
arachidonic acid as fatty acid, the absence of effect observed by us
cannot be ascribed to our use of a saturated fatty acid for the
investigation.
In accordance with the present observations, studies of muscle
mitochondria with physiologically induced increased levels of UCP3
[13,42] have not indicated an increased ability of fatty acids to
uncouple when more UCP3 is present.
Thus, in general, we ﬁnd there is presently no evidence that
endogenous UCP3 can be induced by fatty acids to function as a proton
leak over the mitochondrial membrane.
4.3.2. Reactive oxygen species as potential UCP3 activity inducers
Original observations indicated an ability of exogenous superoxide
(artiﬁcially produced by addition of xanthine+xanthine oxidase) to
induce increased proton leakage in mitochondria fromwildtype mice,
and that these effects were not seen in muscle mitochondria from
UCP3(−/−) mice [30]. Superoxide should thus be an inducer of UCP3
uncoupling activity.
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xanthine oxidase system is somewhat complex [56], we here tested
whether induced endogenous superoxide production would display
differences between wildtype and UCP3(−/−) mitochondria. Mito-
chondria respiring on succinate in the absence of rotenone have the
highest known levels of endogenous superoxide production. That a
high superoxide production is observed under these conditions is well
demonstrated [54,57], earlier veriﬁed by us in skeletal muscle
mitochondria [18,19] and also directly demonstrated here (Fig. 3).
However, we did not see any difference in the basal respiratory rate
between wildtype and UCP3(−/−) muscle mitochondria when
examined under these conditions (Fig. 4B). This observation is
principally in agreement with results by Lombardi et al. [38] and
thus imply that endogenous superoxide cannot activate an uncou-
pling activity of UCP3.
Further in line with these observations of an absence of effect of
ablation of UCP3, studies examining whether physiologically induced
increased levels of UCP3 lead to higher ROS-increased respiratory
rates have failed to observe such effects [13,39,58,59].
We conclude that superoxide is unable to activate UCP3-mediated
mitochondrial uncoupling under our experimental conditions, sug-
gesting that a function of UCP3 as a protector against oxidative
damage via ROS-induced activation of UCP3 is not likely, in contrast to
what has been suggested [3,4,60].
We also tested the possibility that a ROS effect would only
manifest if ROS were present in combination with fatty acids. We did
not observe any such synergic effect (Fig. 4); if anything the
uncoupling effect of fatty acids was lower under conditions where
ROS was produced (but this may be a technical limitation due to
succinate oxidation inhibition by fatty acids).
4.3.3. 4-HNE as a potential UCP3 activity inducer
4-hydroxynonenal (4-HNE) has also been implied to be able to
induce UCP3-mediated uncoupled respiration [61]. However, accord-
ing to that paper, the presence of UCP3 is not essential for the 4-HNE-
induced response, and a quantitative difference between the response
of wildtype and UCP3(−/−) muscle mitochondria was not clearly
discernable. Recent observations conﬁrm this picture [49]. In the
present paper, we did not examine 4-HNE as a potential UCP3-
activator, but this has recently been done by Aguirre and Cadenas [39].
Their state-4 respiratory data do not show any effect of the presence
of UCP3 on HNE-induced respiratory increase inmusclemitochondria,
and in our opinion this means that an HNE-induced proton leak is not
mediated by UCP3. (Even when estimated as calculated proton leak, it
would seem that UCP3 only is responsible for≈25% of the response to
HNE in muscle (Figs. 3–5 in [39])—but, bioenergetically confounding,
the proton leak calculated in this way does thus not correspond to an
augmented state-4 respiration, and what such a leak measurement
represents is therefore difﬁcult to understand). There is no mediation
at all of any HNE effect by UCP3 in heart mitochondria, neither
measured as state-4 respiration rate, nor as calculated proton leak
[39].
Thus, presently there are no data that conﬁrm that UCP3 is an
uncoupling protein, neither in its native state, nor when examined in
the presence of suggested activators, such as fatty acids, endogenously
produced ROS, combinations of these, or 4-HNE.
4.4. UCP3 and protection against lipotoxicity
UCP3 has been suggested to protect against lipotoxicity, e.g. by
transporting fatty acids out of the mitochondria. Accordingly, UCP3
expression is elevated under lipotoxic conditions [6,62,63]. We tested
here more directly two experimental models of acute lipotoxicity:
fatty acid-induced inhibition of oxidation and fatty acid-induced
mitochondrial swelling. In neither of these did we see an acute
protective effect of the presence of UCP3.It can clearly not be ruled out that UCP3 under other experimental
conditions than those used here can protect against negative effects of
fatty acids, but such conditions would need to be deﬁned.
4.5. UCP3 and oxidative stress
UCP3has been implicated in theprotection against oxidative damage
(e.g. [6,8–11]). However,wedid not observe here anyprotective effect of
UCP3 against oxidative damage. This may be considered remarkable in
the context that practically any review on the function of UCP3 (or any
introduction part in primary papers on UCP3) states that “UCP3 protects
against oxidative damage”.
Two original papers are normally quoted for demonstrating that
the absence of UCP3 promotes oxidative damage. One is the paper by
Vidal-Puig et al. [36] in which the UCP3(−/−) mitochondria also
demonstrated a lower basal respiration; as discussed above this
difference cannot be observed in backcrossed mice by any group
today. Probably, the effects on lucigenin-derived chemiluminescense
and on aconitase observed in that paper may also be related to the use
of non-backcrossed mice. The second paper is that of Brand et al. [64]
where different markers of oxidative damage were examined with
CG/MS techniques. They reported that aminoadipic semialdehyde and
N-(carboxymethyl)-lysine were signiﬁcantly higher in the UCP3
underexpressers (Pb0.05) than in the controls used, and that N-
(carboxyethyl)-lysine (Pb0.10) and glutamic semialdehyde and N-
(malondialdehyde)-lysine (both Pb0.15) tended to be increased in
the UCP3 underexpressers, however without the differences reaching
normal levels of statistical signiﬁcance. These were early investiga-
tions and the mice were not backcrossed. As the access to mice at that
time was limited, the UCP3 underexpressers (n=6) were a combined
group of homozygotic UCP3(−/−) mice and heterozygotic UCP3(−/+)
mice (these likely had diminished levels of UCP3 protein—but it was
not absent [37]), and the control group used (n=9) was a combined
group of the UCP3(+/+) homozygote littermates for these and a
group of transgene-negative littermates from a strain of mice that
were transgenic overexpressers of UCP3. This paper, which is widely
quoted, constitutes the main direct evidence for a protective innate
role of UCP3.
In contrast to expectations from these two paperswe did not observe
any protection by UCP3 against oxidative damage, as examined by three
methods: 4-HNEadduct level andamountofprotein carbonyls in isolated
mitochondria (implied to reﬂect the level of oxidative damage in-vivo)—
or 4-HNE adduct levels following an in-vitro incubation. In agreement
with our observation of identical levels of 4-HNE adducts, Seifert et al.
[53] observed no increase in 4-HNE adduct levels in UCP3(−/−) muscle
mitochondria under normal conditions, although ROS-related effects
assigned to UCP3 have been observed in backcrossed UCP3(−/−) mice
under certain conditions [28,53].
We are not aware of any studies showing that physiologically
induced increases in UCP3 amount are associated with diminished
levels of oxidative damage. There are papers that—in their title—imply
that a protection against oxidative damage by UCP3 has been
observed [65,66]. These papers show that a ROS increase generally
is associated with an increased UCP3 gene expression. Thus these
papers cannot as such be seen as support for a role for UCP3 against
oxidative stress (in reality, these papersmay equally well be quoted as
indicating a function for UCP3 as an inducer, not protector, of ROS
production).
5. Conclusions
Early suggestions for UCP3 function have mainly been based on
experiments performed with mice that have not been backcrossed.
There is increasing awareness that differences between observations
performed on genetically modiﬁed mice that are not backcrossed to a
single strain may include erroneous outcomes, caused not by true
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have therefore felt it necessary to re-examine some of the basic
observations relating to UCP3 function in backcrossed UCP3(−/−)
mice. Among the tenets we examined (basal respiration, ROS
production, reactive oxygen species- or fatty acid-induced respiration,
and protection against acute lipotoxicity and against oxidative
damage), we could not conﬁrm that any of these could withstand
the tests when performed on isolated mitochondrial from back-
crossed mice. Clearly, it cannot be excluded that we may not have
chosen conditions that allow the effects studied to be revealed. We
conclude that the currently available data do not support a function
for UCP3 in mitochondrial uncoupling or protection against acute
lipotoxicity or against oxidative damage.
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